» Articles » PMID: 29875137

Acellular Human Lung Scaffolds to Model Lung Disease and Tissue Regeneration

Overview
Journal Eur Respir Rev
Specialty Pulmonary Medicine
Date 2018 Jun 8
PMID 29875137
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in whole lung bioengineering have opened new doors for studying lung repair and regeneration using acellular human derived lung tissue scaffolds. Methods to decellularise whole human lungs, lobes or resected segments from normal and diseased human lungs have been developed using both perfusion and immersion based techniques. Immersion based techniques allow laboratories without access to intact lobes the ability to generate acellular human lung scaffolds. Acellular human lung scaffolds can be further processed into small segments, thin slices or extracellular matrix extracts, to study cell behaviour such as viability, proliferation, migration and differentiation. Recent studies have offered important proof of concept of generating sufficient primary endothelial and lung epithelial cells to recellularise whole lobes that can be maintained for several days in a bioreactor to study regeneration. In parallel, acellular human lung scaffolds have been increasingly used for studying cell-extracellular environment interactions. These studies have helped provide new insights into the role of the matrix and the extracellular environment in chronic human lung diseases such as chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Acellular human lung scaffolds are a versatile new tool for studying human lung repair and regeneration .

Citing Articles

Advancements in lung regeneration: from bench to bedside.

Khayatan D, Barzegar P, Fatima A, Sattar T, Zahid A, Batool S J Transl Med. 2025; 23(1):154.

PMID: 39905476 PMC: 11796163. DOI: 10.1186/s12967-024-05954-6.


Enhancing Lung Recellularization with Mesenchymal Stem Cells via Photobiomodulation Therapy: Insights into Cytokine Modulation and Sterilization.

Guimaraes L, Brito A, Cereta A, Oliveira A, Afonso J, Mello D Int J Mol Sci. 2024; 25(18).

PMID: 39337615 PMC: 11432310. DOI: 10.3390/ijms251810131.


A roadmap for developing and engineering pulmonary fibrosis models.

Dabaghi M, Carpio M, Saraei N, Moran-Mirabal J, Kolb M, Hirota J Biophys Rev (Melville). 2024; 4(2):021302.

PMID: 38510343 PMC: 10903385. DOI: 10.1063/5.0134177.


The evolution of models of lung fibrosis: promising prospects for drug discovery.

Kolanko E, Cargnoni A, Papait A, Silini A, Czekaj P, Parolini O Eur Respir Rev. 2024; 33(171).

PMID: 38232990 PMC: 10792439. DOI: 10.1183/16000617.0127-2023.


In vitro co-culture studies and the crucial role of fibroblast-immune cell crosstalk in IPF pathogenesis.

Thiam F, Phogat S, Abokor F, Osei E Respir Res. 2023; 24(1):298.

PMID: 38012580 PMC: 10680329. DOI: 10.1186/s12931-023-02608-x.


References
1.
Parker M, Rossi D, Peterson M, Smith K, Sikstrom K, White E . Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest. 2014; 124(4):1622-35. PMC: 3971953. DOI: 10.1172/JCI71386. View

2.
Wagner D, Bonenfant N, Parsons C, Sokocevic D, Brooks E, Borg Z . Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials. 2014; 35(10):3281-97. PMC: 4215725. DOI: 10.1016/j.biomaterials.2013.12.103. View

3.
Mendez J, Ghaedi M, Steinbacher D, Niklason L . Epithelial cell differentiation of human mesenchymal stromal cells in decellularized lung scaffolds. Tissue Eng Part A. 2014; 20(11-12):1735-46. PMC: 4029048. DOI: 10.1089/ten.TEA.2013.0647. View

4.
Wainwright D . Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns. 1995; 21(4):243-8. DOI: 10.1016/0305-4179(95)93866-i. View

5.
Ren X, Moser P, Gilpin S, Okamoto T, Wu T, Tapias L . Engineering pulmonary vasculature in decellularized rat and human lungs. Nat Biotechnol. 2015; 33(10):1097-102. DOI: 10.1038/nbt.3354. View